Literature DB >> 9694149

Interstitial laser coagulation: evaluation of the effect of normal liver blood perfusion and the application mode on lesion size.

D Albrecht1, C T Germer, C Isbert, J P Ritz, A Roggan, G Müller, H J Buhr.   

Abstract

BACKGROUND AND
OBJECTIVE: The effect of temporarily interrupted hepatic blood flow and multiple-fiber application on necrosis volume in interstitial laser coagulation (ILC) was investigated. STUDY DESIGN/
MATERIALS AND METHODS: Single- and multiple-fiber ILC were performed in porcine livers with normal as well as interrupted perfusion. Temperatures were determined. Lesions were measured and studied by light microscopy 4 hours post-treatment.
RESULTS: ILC with multiple-fiber application led to significantly greater individual lesion volumes (3.7 +/- 0.5 cm3) than single-fiber application (2.5 +/- 0.5 cm3) (P < .01). The interruption of hepatic perfusion led to a significant increase in lesion volume with single- (7.5 +/- 1.0 cm3) as well as multiple-fiber application (12.6 +/- 2.2 cm3) (P < .01). Superposition of the lesions in the multiple-fiber application mode was only determined with interrupted perfusion (total volume: 50.3 +/- 6.6 cm3).
CONCLUSION: Interruption of hepatic perfusion increases lesion volumes significantly. ILC for treating liver tumors should preferably be performed by application routes that permit temporary interruption of hepatic perfusion.

Entities:  

Mesh:

Year:  1998        PMID: 9694149     DOI: 10.1002/(sici)1096-9101(1998)23:1<40::aid-lsm6>3.0.co;2-w

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  8 in total

1.  Reduction of collateral thermal impact of diode laser irradiation on soft tissue due to modified application parameters.

Authors:  F Beer; W Körpert; H Passow; A Steidler; A Meinl; A G Buchmair; A Moritz
Journal:  Lasers Med Sci       Date:  2011-10-28       Impact factor: 3.161

2.  Dynamic modeling of photothermal interactions for laser-induced interstitial thermotherapy: parameter sensitivity analysis.

Authors:  S C Jiang; X X Zhang
Journal:  Lasers Med Sci       Date:  2005-11-19       Impact factor: 3.161

3.  Effectiveness of various thermal ablation techniques for the treatment of nodular thyroid disease--comparison of laser-induced thermotherapy and bipolar radiofrequency ablation.

Authors:  Jörg-Peter Ritz; Kai S Lehmann; Thomas Schumann; Verena Knappe; Urte Zurbuchen; Heinz J Buhr; Christoph Holmer
Journal:  Lasers Med Sci       Date:  2011-04-01       Impact factor: 3.161

4.  Magnetic resonance temperature imaging-based quantification of blood flow-related energy losses.

Authors:  Christopher Dillon; Robert Roemer; Allison Payne
Journal:  NMR Biomed       Date:  2015-05-14       Impact factor: 4.044

5.  Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT).

Authors:  Stephan Zangos; Katrin Eichler; Jörn O Balzer; Ralf Straub; Renate Hammerstingl; Christopher Herzog; Thomas Lehnert; Mathias Heller; Axel Thalhammer; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-08-08       Impact factor: 5.315

6.  Laser-induced thermotherapy combined with hepatic arterial embolization in the treatment of liver tumors in a rat tumor model.

Authors:  C T Germer; C Isbert; D Albrecht; A Roggan; J Pelz; J P Ritz; G Müller; H J Buhr
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

7.  Clinical efficacy of bipolar radiofrequency ablation of small renal masses.

Authors:  S G C Kroeze; M Agenant; G N Jonges; T Stein; J L H R Bosch
Journal:  World J Urol       Date:  2014-10-29       Impact factor: 4.226

8.  Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma.

Authors:  T J Vogl; A Jost; N A Nour-Eldin; M G Mack; S Zangos; N N N Naguib
Journal:  Br J Cancer       Date:  2012-03-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.